Beyond the intestinal celiac mucosa: diagnostic role of anti TG2 deposits, a systematic review

Beyond the intestinal celiac mucosa: diagnostic role of anti TG2 deposits, a systematic review

Abstract <br/>Aim: to review the existing literature on the role and significance of intestinal transglutaminase 2 IgA deposits (TG2 deposits) in patients with overt CD, potential CD and other autoimmune or gluten-related conditions. <br/>Methods: we conducted a systematic review of st...

Full description

Bibliographic Details
Main Authors:	Simona eGatti, Matilde eRossi, Simona eAlfonsi, Alessandra eMandolesi, Giovanni eCobellis, Carlo eCatassi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-05-01
Series:	Frontiers in Medicine
Subjects:	Celiac Disease Dermatitis Herpetiformis immunofluorescence intestinal deposits anti-tissue transglutaminase 2 potential celiac disease
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmed.2014.00009/full

Similar Items

Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease
by: Helka Kaunisto, et al.
Published: (2022-03-01)

Urticarial dermatitis herpetiformis: A rare presentation of an uncommon disorder
by: Rachel Sally, BA, et al.
Published: (2022-08-01)

Celiac disease presenting as dermatitis herpetiformis: A case report
by: Ali Kirik, et al.
Published: (2020-12-01)

Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment
by: Marcos Vinícius Clarindo, et al.
Published: (2014-12-01)

Dermatitis herpetiformis: celiac disease of the skin. Report of two cases
by: Beatriz Di Martino Ortiz, Hugo Macchi, et al.
Published: (2019-01-01)

Separate Gut Plasma Cell Populations Produce Auto‐Antibodies against Transglutaminase 2 and Transglutaminase 3 in Dermatitis Herpetiformis
by: Saykat Das, et al.
Published: (2023-09-01)

Anti-tissue transglutaminase antibodies and EEG pattern in celiac patients on prolonged gluten-free diet
by: A. Berio, et al.
Published: (2013-01-01)

The Detection of Silent Celiac Disease In patients With Type 1 Diabetes Mellitus by the use of Anti Tissue Transglutaminase Antibodies
by: Anower Tuama Obaid, et al.
Published: (2012-06-01)

The Detection of Silent Celiac Disease In patients With Type 1 Diabetes Mellitus by the use of Anti Tissue Transglutaminase Antibodies
by: Anower Tuama Obaid, et al.
Published: (2012-12-01)

Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis
by: Esko Kemppainen, et al.
Published: (2021-03-01)

Untreated Celiac Disease in a Patient with Dermatitis Herpetiformis Leading to a Small Bowel Carcinoma
by: Monique H.M. Derikx, et al.
Published: (2012-01-01)

Dermatitis herpetiformis Duhring as one of the forms of gluten-associated pathology: a review of the literature and a description of a clinical case
by: L. Ya. Klimov, et al.
Published: (2022-03-01)

Development of Dermatitis Herpetiformis in Chronic Plaque Psoriasis
by: Ruby Lee, et al.
Published: (2021-02-01)

Celiac Crisis
by: Rômulo Ribeiro do Vale, et al.
Published: (2018-08-01)

Celiac crisis, atypical form of celiac disease onset in teenager – a case report
by: Daniela Ciobanu, et al.
Published: (2020-12-01)

Usefulness of a double immunofluorescence technique for detection of intestinal tTG-IgA deposits in diabetic and non-diabetic children with celiac disease
by: Raghav Lal, et al.
Published: (2023-07-01)

Survey of the initial management of celiac disease antibody tests by ordering physicians
by: Kathryn Potter, et al.
Published: (2019-07-01)

Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease
by: Christian Büchold, et al.
Published: (2022-05-01)

Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
by: Eremić Nevena, et al.
Published: (2012-01-01)

Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages
by: Enzo Ierardi, et al.
Published: (2015-01-01)

Case report on pathogenetic link between gluten and IgA nephropathy
by: Stefano Costa, et al.
Published: (2018-05-01)

Development of celiac-safe foods: prevention of transglutaminase 2 (TG2) deamidation of gluten in healthy non-celiac volunteers
by: Niklas Engström, et al.
Published: (2024-03-01)

IMMUNE MEDIATED DISEASES IN PATIENTS WITH CELIAC DISEASE AND THEIR RELATIVES: A COMPARATIVE STUDY OF AGE AND SEX
by: Lorete Maria da Silva KOTZE, et al.

Prevalence of Celiac disease in north of Iran: Screening of an adult population in Sari
by: H.Tirgar-Fakheri (M.D), et al.
Published: (2004-03-01)

Prevalence and clinical features of celiac disease in patients with autoimmune thyroiditis: cross-sectional study
by: Aline Ventura, et al.

Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years
by: Anna Rita Di Biase, et al.
Published: (2021-11-01)

Diagnostic challenges in children with celiac disease. A five-year experience with new guidelines in a General Pediatrics Department
by: Daniela Pop, et al.
Published: (2023-03-01)

Prevalence of Tissue Transglutamase Antibodies in cases of Celiac Disease
by: Samreen Soomro, et al.
Published: (2015-04-01)

Prevalence of Tissue Transglutamase Antibodies in cases of Celiac Disease
by: Samreen Soomro, et al.
Published: (2015-04-01)

Role of age in dynamics of autoantibodies in pediatric Celiac disease
by: Chiara Maria Trovato, et al.
Published: (2023-03-01)

Oral Lichen Planus and Celiac Disease: is there any Relationship?
by: Atessa Pakfetrat, et al.
Published: (2020-07-01)

Prevalence of Tissue Transglutamase Antibodies in cases of Celiac Disease
by: Samreen Soomro, et al.
Published: (2015-04-01)

Clinical and demographic comparison of celiac disease diagnosed during adulthood versus childhood and adolescence: A single‐center experience
by: Ajay K Jain, et al.
Published: (2023-12-01)

Changes in Non-Deamidated versus Deamidated Epitope Targeting and Disease Prediction during the Antibody Response to Gliadin and Transglutaminase of Infants at Risk for Celiac Disease
by: Ádám Diós, et al.
Published: (2022-02-01)

Celiac disease in the XIX, XX and XXI century
by: A I Parfenov
Published: (2003-02-01)

Diagnostic Accuracy of IgA Anti-Transglutaminase and IgG Anti-Deamidated Gliadin for Diagnosis of Celiac Disease in Children under Two Years of Age: A Systematic Review and Meta-Analysis
by: Giulia N. Catassi, et al.
Published: (2021-12-01)

Reliability of the Multiplex CytoBead CeliAK Immunoassay to Assess Anti-tTG IgA for Celiac Disease Screening
by: Diyora Abdukhakimova, et al.
Published: (2021-09-01)

Generalized edema as the dominant clinical symptom of celiac crisis
by: Dominika Wilczyńska, et al.
Published: (2021-12-01)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
by: Sebastian Stricker, et al.
Published: (2022-02-01)

Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
by: Stefania Martucciello, et al.
Published: (2020-05-01)